2026 Global: Blood Processing Devices Market -Competitive Review (2032) report
Description
The 2026 Global: Blood Processing Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Global blood processing devices are produced by a handful of diversified manufacturers with global footprints. Terumo Corporation, headquartered in Tokyo, Japan, supplies integrated apheresis and cell-processing systems, complemented by consumables and software. Fresenius Kabi, based in Bad Homburg vor der Höhe, Germany, emphasizes large-scale plasma collection and blood component processing, together with accompanying services. Haemonetics Corporation, headquartered in Braintree, Massachusetts, United States, focuses on portable and hospital-based attribute-driven apheresis platforms, along with data management and analytics. Grifols, S.A., headquartered in Barcelona, Spain, leverages its plasma-derived therapies to drive proprietary blood-banking equipment and process automation across centers. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, United States, maintains a broad portfolio of collection sets, separators, and diagnostics that underpin acute care and transfusion medicine. Collectively, these firms define the standards of precision, sterility, and interoperability in automated blood processing. Their products enable standardized workflows across global blood centers.
Immucor, Inc., headquartered in Norcross, Georgia, United States, specializes in blood-typing and crossmatching platforms that underpin pre-transfusion compatibility testing and automation in immunohematology. Getinge AB, headquartered in Getinge, Sweden, supplies blood-bank refrigerators, automated cell processors, and sterile handling systems, integrating infection control and traceability across facilities. Baxter International Corporation, based in Deerfield, Illinois, United States, continues to offer Fenwal-brand blood collection and component-separation devices deployed by major hospitals worldwide, complementing its broader portfolio in transfusion medicine. Macopharma, headquartered in Lyon, France, develops blood bags, sterile containers, and related consumables that support blood collection, processing, and storage in regional centers. Nipro Corporation, headquartered in Osaka, Japan, provides a range of disposable devices, tubing sets, and automated systems designed to streamline donation, processing, and storage workflows across the supply chain. Together, these firms drive efficiency, safety, and standardization in critical blood-collection and processing operations worldwide. Their global coverage supports swift responses worldwide.
Together, the ten firms shape the competitive dynamics, driving investments in automation, closed-system biobanking, and real-time data integration. Across regions, Terumo and BD emphasize interoperability standards through open communication protocols, while Grifols and Fresenius Kabi expand plasma processing capabilities to meet rising demand for therapies and plasma-derived products. Immucor complements these developments by delivering immune-compatibility solutions that reduce transfusion risks, and Getinge, Baxter, Macopharma, and Nipro advance the engineering of sterile consumables, scalable storage, and user-friendly interfaces. In mature markets, evidence-based procurement and hospital-aligned service models increasingly determine market share, whereas emerging economies reward cost-effective, modular platforms. Regulatory scrutiny and quality assurance remain critical, shaping supplier qualification and post-market surveillance. Collectively, these ten players offer an integrated ecosystem spanning collection, separation, storage, and administration—an ecosystem that underpins modern transfusion medicine, enables safer patient outcomes, and supports rapid responses to blood supply disruptions. Continued collaboration will propel innovation and resilience globally.
Global blood processing devices are produced by a handful of diversified manufacturers with global footprints. Terumo Corporation, headquartered in Tokyo, Japan, supplies integrated apheresis and cell-processing systems, complemented by consumables and software. Fresenius Kabi, based in Bad Homburg vor der Höhe, Germany, emphasizes large-scale plasma collection and blood component processing, together with accompanying services. Haemonetics Corporation, headquartered in Braintree, Massachusetts, United States, focuses on portable and hospital-based attribute-driven apheresis platforms, along with data management and analytics. Grifols, S.A., headquartered in Barcelona, Spain, leverages its plasma-derived therapies to drive proprietary blood-banking equipment and process automation across centers. Becton, Dickinson and Company (BD), based in Franklin Lakes, New Jersey, United States, maintains a broad portfolio of collection sets, separators, and diagnostics that underpin acute care and transfusion medicine. Collectively, these firms define the standards of precision, sterility, and interoperability in automated blood processing. Their products enable standardized workflows across global blood centers.
Immucor, Inc., headquartered in Norcross, Georgia, United States, specializes in blood-typing and crossmatching platforms that underpin pre-transfusion compatibility testing and automation in immunohematology. Getinge AB, headquartered in Getinge, Sweden, supplies blood-bank refrigerators, automated cell processors, and sterile handling systems, integrating infection control and traceability across facilities. Baxter International Corporation, based in Deerfield, Illinois, United States, continues to offer Fenwal-brand blood collection and component-separation devices deployed by major hospitals worldwide, complementing its broader portfolio in transfusion medicine. Macopharma, headquartered in Lyon, France, develops blood bags, sterile containers, and related consumables that support blood collection, processing, and storage in regional centers. Nipro Corporation, headquartered in Osaka, Japan, provides a range of disposable devices, tubing sets, and automated systems designed to streamline donation, processing, and storage workflows across the supply chain. Together, these firms drive efficiency, safety, and standardization in critical blood-collection and processing operations worldwide. Their global coverage supports swift responses worldwide.
Together, the ten firms shape the competitive dynamics, driving investments in automation, closed-system biobanking, and real-time data integration. Across regions, Terumo and BD emphasize interoperability standards through open communication protocols, while Grifols and Fresenius Kabi expand plasma processing capabilities to meet rising demand for therapies and plasma-derived products. Immucor complements these developments by delivering immune-compatibility solutions that reduce transfusion risks, and Getinge, Baxter, Macopharma, and Nipro advance the engineering of sterile consumables, scalable storage, and user-friendly interfaces. In mature markets, evidence-based procurement and hospital-aligned service models increasingly determine market share, whereas emerging economies reward cost-effective, modular platforms. Regulatory scrutiny and quality assurance remain critical, shaping supplier qualification and post-market surveillance. Collectively, these ten players offer an integrated ecosystem spanning collection, separation, storage, and administration—an ecosystem that underpins modern transfusion medicine, enables safer patient outcomes, and supports rapid responses to blood supply disruptions. Continued collaboration will propel innovation and resilience globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
